- Home
- Publications
- Publication Search
- Publication Details
Title
Narrow-spectrum antibacterial agents
Authors
Keywords
-
Journal
MedChemComm
Volume 9, Issue 1, Pages 12-21
Publisher
Royal Society of Chemistry (RSC)
Online
2017-11-06
DOI
10.1039/c7md00528h
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
- (2017) Travis B Nielsen et al. JOURNAL OF INFECTIOUS DISEASES
- Reducing global tuberculosis deaths—time for India to step up
- (2017) Madhukar Pai et al. LANCET
- A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail
- (2017) Debra A Goff et al. LANCET INFECTIOUS DISEASES
- Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
- (2017) Richard J Vickers et al. LANCET INFECTIOUS DISEASES
- Targeted antimicrobial therapy in the microbiome era
- (2017) V.N. Stone et al. Molecular Oral Microbiology
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- 6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis
- (2017) Amy S. T. Tong et al. ACS Medicinal Chemistry Letters
- Antibiotic exposure perturbs the gut microbiota and elevates mortality in honeybees
- (2017) Kasie Raymann et al. PLOS BIOLOGY
- Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors
- (2017) Ursula Waack et al. Frontiers in Cellular and Infection Microbiology
- The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?
- (2017) Roberta J. Melander et al. ACS Infectious Diseases
- Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae — Washoe County, Nevada, 2016
- (2017) Lei Chen et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
- (2017) Giulia Degiacomi et al. Scientific Reports
- Identification of the ESKAPE pathogens by mass spectrometric analysis of microbial membrane glycolipids
- (2017) Lisa M. Leung et al. Scientific Reports
- Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed
- (2017) Matthew F. Wipperman et al. Scientific Reports
- New agents for the treatment of drug-resistant Mycobacterium tuberculosis
- (2016) Daniel T. Hoagland et al. ADVANCED DRUG DELIVERY REVIEWS
- Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections
- (2016) James M. Regeimbal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii
- (2016) Mya Thandar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults
- (2016) Xiang-Qing Yu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ridinilazole: a novel therapy for Clostridium difficile infection
- (2016) Richard J. Vickers et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnostics
- (2016) Tucker Maxson et al. TETRAHEDRON
- Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway
- (2016) Subramanyam J. Tantry et al. MedChemComm
- 1,2,4-Triazolidine-3-thiones as Narrow Spectrum Antibiotics against Multidrug-Resistant Acinetobacter baumannii
- (2016) William M. Huggins et al. ACS Medicinal Chemistry Letters
- Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficileCompounds Fidaxomicin and LFF571
- (2016) Jennifer A. Leeds Cold Spring Harbor Perspectives in Medicine
- The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation
- (2016) Amy Langdon et al. Genome Medicine
- Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options
- (2016) S.M. Purrello et al. Journal of Global Antimicrobial Resistance
- 1,2,4-Triazolidine-3-thiones Have Specific Activity against Acinetobacter baumannii among Common Nosocomial Pathogens
- (2016) Brendan W. Corey et al. ACS Infectious Diseases
- A multi-center study of fidaxomicin use for Clostridium difficile infection
- (2016) Dhara N. Shah et al. SpringerPlus
- Microbial diagnosis of bloodstream infection: towards molecular diagnosis directly from blood
- (2015) O. Opota et al. CLINICAL MICROBIOLOGY AND INFECTION
- The effect of past antibiotic exposure on diabetes risk
- (2015) B. Boursi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Antibiotics: the changing regulatory and pharmaceutical industry paradigm
- (2015) Richard Bax et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synthesis and Evaluation of 1,2,4-Triazolo[1,5-a]pyrimidines as Antibacterial Agents Against Enterococcus faecium
- (2015) Huan Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- ESKAPEing the labyrinth of antibacterial discovery
- (2015) Ruben Tommasi et al. NATURE REVIEWS DRUG DISCOVERY
- Risks of Antibiotic Exposures Early in Life on the Developing Microbiome
- (2015) Anjelique Schulfer et al. PLoS Pathogens
- Survey of Physicians’ Perspectives and Knowledge about Diagnostic Tests for Bloodstream Infections
- (2015) Rosemary C. She et al. PLoS One
- The evolution of the regulatory framework for antibacterial agents
- (2014) John H. Rex et al. Annals of the New York Academy of Sciences
- Design and recombination expression of a novel plectasin-derived peptide MP1106 and its properties against Staphylococcus aureus
- (2014) Xintao Cao et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Antibiotic Adjuvants: Diverse Strategies for Controlling Drug-Resistant Pathogens
- (2014) Erin E. Gill et al. Chemical Biology & Drug Design
- MALDI-TOF MS for the Diagnosis of Infectious Diseases
- (2014) R. Patel CLINICAL CHEMISTRY
- Risk Factors and Outcome Analysis of Acinetobacter baumannii Complex Bacteremia in Critical Patients*
- (2014) Hao-Yuan Lee et al. CRITICAL CARE MEDICINE
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- FDA Approval of Bedaquiline — The Benefit–Risk Balance for Drug-Resistant Tuberculosis
- (2014) Edward Cox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commensal bacteria protect against food allergen sensitization
- (2014) A. T. Stefka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
- (2014) A. DiGiandomenico et al. Science Translational Medicine
- Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043
- (2014) Rohit Tiwari et al. ACS Medicinal Chemistry Letters
- O serotype-independent susceptibility ofPseudomonas aeruginosato lectin-like pyocins
- (2014) Maarten G. K. Ghequire et al. MicrobiologyOpen
- ComparativeIn VitroActivities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates
- (2013) Ellie J. C. Goldstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Better Tests, Better Care: Improved Diagnostics for Infectious Diseases
- (2013) A. M. Caliendo et al. CLINICAL INFECTIOUS DISEASES
- Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection
- (2013) M. C. Rea et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
- (2013) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
- (2013) Oluseye K. Onajole et al. JOURNAL OF MEDICINAL CHEMISTRY
- The value of single-pathogen antibacterial agents
- (2013) Brad Spellberg et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
- (2013) F. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indoleamides are active against drug-resistant Mycobacterium tuberculosis
- (2013) Shichun Lun et al. Nature Communications
- Local resistance patterns to antimicrobials in internal medicine: a focused report from the REGIMEN (REGistro Infezioni in MEdicina INterna) study
- (2012) Marco Cei et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Bacteriocins — a viable alternative to antibiotics?
- (2012) Paul D. Cotter et al. NATURE REVIEWS MICROBIOLOGY
- Antibiotics, microbiota, and immune defense
- (2012) Carles Ubeda et al. TRENDS IN IMMUNOLOGY
- Intrinsic and acquired resistance mechanisms in enterococcus
- (2012) Brian L. Hollenbeck et al. Virulence
- Rapid Diagnostics and Appropriate Antibiotic Use
- (2011) Louis B. Rice CLINICAL INFECTIOUS DISEASES
- Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
- (2011) V. Stevens et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Activity of Fidaxomicin (OPT-80) Tested against Contemporary Clinical Isolates of Staphylococcus spp. and Enterococcus spp.
- (2010) D. J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A predicted S-type pyocin shows a bactericidal activity against clinicalPseudomonas aeruginosaisolates through membrane damage
- (2010) Hua Ling et al. FEBS LETTERS
- Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile
- (2010) M. C. Rea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
- (2010) M. C. Rea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II
- (2010) T. Schneider et al. SCIENCE
- The case for pathogen-specific therapy
- (2009) Arturo Casadevall EXPERT OPINION ON PHARMACOTHERAPY
- What are the consequences of the disappearing human microbiota?
- (2009) Martin J. Blaser et al. NATURE REVIEWS MICROBIOLOGY
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
- (2008) Louis B. Rice JOURNAL OF INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started